ES428171A1 - Procedimiento de fabricacion de comprimidos. - Google Patents

Procedimiento de fabricacion de comprimidos.

Info

Publication number
ES428171A1
ES428171A1 ES428171A ES428171A ES428171A1 ES 428171 A1 ES428171 A1 ES 428171A1 ES 428171 A ES428171 A ES 428171A ES 428171 A ES428171 A ES 428171A ES 428171 A1 ES428171 A1 ES 428171A1
Authority
ES
Spain
Prior art keywords
tablets
capsules
manufacture
release micro
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES428171A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Publication of ES428171A1 publication Critical patent/ES428171A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
ES428171A 1973-07-12 1974-07-11 Procedimiento de fabricacion de comprimidos. Expired ES428171A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7325531A FR2236483B1 (es) 1973-07-12 1973-07-12

Publications (1)

Publication Number Publication Date
ES428171A1 true ES428171A1 (es) 1976-07-16

Family

ID=9122459

Family Applications (1)

Application Number Title Priority Date Filing Date
ES428171A Expired ES428171A1 (es) 1973-07-12 1974-07-11 Procedimiento de fabricacion de comprimidos.

Country Status (11)

Country Link
US (1) US3922338A (es)
JP (1) JPS5736893B2 (es)
BE (1) BE817401A (es)
CA (1) CA1028622A (es)
DE (1) DE2433285C2 (es)
ES (1) ES428171A1 (es)
FR (1) FR2236483B1 (es)
GB (1) GB1469879A (es)
IT (1) IT1016413B (es)
NL (1) NL7409295A (es)
SE (1) SE419161B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4532123A (en) * 1982-03-04 1985-07-30 Battelle Development Corporation Dual Microcapsules and process for their preparation
US4637905A (en) * 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3228533A1 (de) * 1982-07-30 1984-02-02 Council of Scientific and Industrial Research, 110001 New Delhi Verfahren zur herstellung von medizinischen pillen und so hergestellen pillen
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
JPS61501197A (ja) * 1984-03-29 1986-06-19 レツペル−プラステイク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 印刷物の積み降ろし装置
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
EP0190833B1 (en) * 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
JPH0539288U (ja) * 1991-10-31 1993-05-28 三栄源エフ・エフ・アイ株式会社 容器兼用食品
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
US6663896B1 (en) 2001-08-01 2003-12-16 Alvin S. Blum Delayed release aspirin for vascular obstruction prophylaxis
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
DE10306468A1 (de) * 2003-02-14 2004-09-02 Henkel Kgaa Aus Pulver und Mikrokapseln gepreßter Formkörper
BRPI0513089B8 (pt) * 2004-08-04 2021-05-25 Alza Corp forma de dosagem para liberação controlada de um fármaco de ordem ascendente de zero
US20080286344A1 (en) * 2007-05-16 2008-11-20 Olivia Darmuzey Solid form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US462990A (en) * 1891-11-10 William oppenheimek
DE646035C (de) * 1934-03-02 1937-06-07 Fritz Weinmann Dr Verfahren zur Herstellung von Arzneimitteltabletten aus mehreren Schichten
DE657259C (de) * 1936-05-20 1938-03-01 Ludwig Heumann & Co Chem Pharm Pressling fuer pharmazeutische Zwecke
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
FR5788M (es) * 1965-11-18 1968-03-18
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition

Also Published As

Publication number Publication date
DE2433285C2 (de) 1985-02-07
BE817401A (fr) 1975-01-09
US3922338A (en) 1975-11-25
JPS5036619A (es) 1975-04-05
AU7117574A (en) 1976-01-15
NL7409295A (nl) 1975-01-14
FR2236483A1 (es) 1975-02-07
DE2433285A1 (de) 1975-01-30
GB1469879A (en) 1977-04-06
CA1028622A (fr) 1978-03-28
SE7409149L (sv) 1975-01-13
SE419161B (sv) 1981-07-20
JPS5736893B2 (es) 1982-08-06
FR2236483B1 (es) 1976-11-12
IT1016413B (it) 1977-05-30

Similar Documents

Publication Publication Date Title
ES428171A1 (es) Procedimiento de fabricacion de comprimidos.
IL40628A0 (en) New penicillins,their production,and pharmaceutical compositions containing them
GB1204580A (en) Pharmaceutical dosage forms
IE40907B1 (en) Use of melt-sprayed spherical phenacetin granules for the production of tablets
IL40627A0 (en) New penicillin compounds,their production and pharmaceutical compositions containing them
IL40080A0 (en) 4-aza-benzimidazoles,their production and pharmaceutical compositions containing them
AU5682673A (en) Coating of tablets and capsules coating of tablets and capsules
CA985968A (en) Manufacture of microcapsules
CA992549A (en) Indane compounds, processes of making same and their use as fragrance material
IL40220A0 (en) Arylidene cyclanones,their production and pharmaceutical compositions containing them
IL35504A0 (en) New derivatives of hexahydrobenzindole,their production and pharmaceutical compositions containing them
CA922982A (en) Gelatine capsule coatings and a process for their manufacture
CA964129A (en) Manufacture of minute capsules, en masse
IL40051A0 (en) Substituted 2-phenylthiophenes,their production and pharmaceutical compositions containing them
IL39882A0 (en) New diazepine derivatives,their production and pharmaceutical compositions containing them
CA926827A (en) Close packing of uniform size spheres
IL46593A0 (en) New 2-amino-6-dialkylaminodihydropyridines,their production and pharmaceutical compositions containing them
CA939564A (en) Manufacture of minute capsules, en masse, and capsule product
IL39673A0 (en) (o-substituted phenyl)ethylguanidines,their production and pharmaceutical compositions containing them
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
AU486843B2 (en) New tablets containing intheir mass controlled-release microcapsules and process forthe manufacture of said tablets
CA845656A (en) Manufacture of minute capsules, en masse, and product
IL46644A0 (en) New indane derivatives,their production and pharmaceutical compositions containing them
IL46890A0 (en) New-1-aryl-uracils,their production and pharmaceutical compositions containing them
AU408980B2 (en) Process forthe production of tablets bythe pressing of powder mixtures without previous granulation